Atypical ADPKD Due to a Pathogenic Variant: An Educational Case Report

Rationale: Due to next-generation sequencing, variants in new genes such as DNAJB11 are recently being identified as causing atypical autosomal dominant polycystic kidney disease (ADPKD). It is important to describe phenotypes associated with these variants in order to increase awareness among clini...

Full description

Bibliographic Details
Main Authors: Jessica Kachmar, Zaki El-Haffaf, Guillaume Bollée
Format: Article
Language:English
Published: SAGE Publishing 2023-10-01
Series:Canadian Journal of Kidney Health and Disease
Online Access:https://doi.org/10.1177/20543581231203054
_version_ 1797657145775226880
author Jessica Kachmar
Zaki El-Haffaf
Guillaume Bollée
author_facet Jessica Kachmar
Zaki El-Haffaf
Guillaume Bollée
author_sort Jessica Kachmar
collection DOAJ
description Rationale: Due to next-generation sequencing, variants in new genes such as DNAJB11 are recently being identified as causing atypical autosomal dominant polycystic kidney disease (ADPKD). It is important to describe phenotypes associated with these variants in order to increase awareness among clinicians, especially since genetic variability affects ADPKD severity. Presenting Concerns of the Patient: We describe a 55-year-old female patient of Haitian origin who presented with slowly deteriorating kidney function, microscopic hematuria, proteinuria, enlarged kidneys with innumerable small cysts, and a family history of chronic kidney disease and cysts. The phenotype was atypical for ADPKD caused by PKD1 or PKD2 variants, since cysts were of small size, kidneys were only moderately enlarged, and the patient had no extra-renal involvement suggestive of typical ADPKD such as liver cysts, pancreatic cysts, cranial aneurysms, or cardiac abnormalities. Diagnoses: A panel of genes was analyzed by next-generation massive sequencing techniques, including DNAJB11, DZIP1L, GANAB, HNF1B, PKD1, PKD2 , and PKHD1 . Genetic testing revealed a heterozygous variant in the DNAJB11 gene (c.123 dup), which is predicted to result in premature protein termination (p. Lys42*) and was classified by the laboratory as likely pathogenic. Interventions: She was treated with candesartan 16 mg once daily to address her proteinuria. Outcomes: At the time of the most recent follow-up, her proteinuria has increased, and her kidney function continues to slowly deteriorate. Teaching Points: DNAJB11 variants are a rare cause of atypical ADPKD. It is important to recognize the clinical features that help distinguish DNAJB11 from PKD1 and PKD2 variants. Atypical ADPKD due to DNAJB11 variants is usually characterized by small cysts, normal kidney size, proteinuria, progressive chronic kidney disease, and phenotypic overlap with autosomal dominant tubulointerstitial kidney disease (ADTKD). It may, however, present itself with enlarged kidneys as was seen in our patient. Genetic testing should be offered whenever a patient presents atypical features of ADPKD, which also requires increased awareness among clinicians regarding the various phenotypes of atypical ADPKD.
first_indexed 2024-03-11T17:40:09Z
format Article
id doaj.art-cccc9dc97c1846dc9b4fad06d422a693
institution Directory Open Access Journal
issn 2054-3581
language English
last_indexed 2024-03-11T17:40:09Z
publishDate 2023-10-01
publisher SAGE Publishing
record_format Article
series Canadian Journal of Kidney Health and Disease
spelling doaj.art-cccc9dc97c1846dc9b4fad06d422a6932023-10-18T13:03:43ZengSAGE PublishingCanadian Journal of Kidney Health and Disease2054-35812023-10-011010.1177/20543581231203054Atypical ADPKD Due to a Pathogenic Variant: An Educational Case ReportJessica Kachmar0Zaki El-Haffaf1Guillaume Bollée2Division of Nephrology, Department of Medicine, Centre Hospitalier de l’Université de Montréal, QC, CanadaDepartment of Genetics, Centre Hospitalier de l’Université de Montréal, QC, CanadaDivision of Nephrology, Department of Medicine, Centre Hospitalier de l’Université de Montréal, QC, CanadaRationale: Due to next-generation sequencing, variants in new genes such as DNAJB11 are recently being identified as causing atypical autosomal dominant polycystic kidney disease (ADPKD). It is important to describe phenotypes associated with these variants in order to increase awareness among clinicians, especially since genetic variability affects ADPKD severity. Presenting Concerns of the Patient: We describe a 55-year-old female patient of Haitian origin who presented with slowly deteriorating kidney function, microscopic hematuria, proteinuria, enlarged kidneys with innumerable small cysts, and a family history of chronic kidney disease and cysts. The phenotype was atypical for ADPKD caused by PKD1 or PKD2 variants, since cysts were of small size, kidneys were only moderately enlarged, and the patient had no extra-renal involvement suggestive of typical ADPKD such as liver cysts, pancreatic cysts, cranial aneurysms, or cardiac abnormalities. Diagnoses: A panel of genes was analyzed by next-generation massive sequencing techniques, including DNAJB11, DZIP1L, GANAB, HNF1B, PKD1, PKD2 , and PKHD1 . Genetic testing revealed a heterozygous variant in the DNAJB11 gene (c.123 dup), which is predicted to result in premature protein termination (p. Lys42*) and was classified by the laboratory as likely pathogenic. Interventions: She was treated with candesartan 16 mg once daily to address her proteinuria. Outcomes: At the time of the most recent follow-up, her proteinuria has increased, and her kidney function continues to slowly deteriorate. Teaching Points: DNAJB11 variants are a rare cause of atypical ADPKD. It is important to recognize the clinical features that help distinguish DNAJB11 from PKD1 and PKD2 variants. Atypical ADPKD due to DNAJB11 variants is usually characterized by small cysts, normal kidney size, proteinuria, progressive chronic kidney disease, and phenotypic overlap with autosomal dominant tubulointerstitial kidney disease (ADTKD). It may, however, present itself with enlarged kidneys as was seen in our patient. Genetic testing should be offered whenever a patient presents atypical features of ADPKD, which also requires increased awareness among clinicians regarding the various phenotypes of atypical ADPKD.https://doi.org/10.1177/20543581231203054
spellingShingle Jessica Kachmar
Zaki El-Haffaf
Guillaume Bollée
Atypical ADPKD Due to a Pathogenic Variant: An Educational Case Report
Canadian Journal of Kidney Health and Disease
title Atypical ADPKD Due to a Pathogenic Variant: An Educational Case Report
title_full Atypical ADPKD Due to a Pathogenic Variant: An Educational Case Report
title_fullStr Atypical ADPKD Due to a Pathogenic Variant: An Educational Case Report
title_full_unstemmed Atypical ADPKD Due to a Pathogenic Variant: An Educational Case Report
title_short Atypical ADPKD Due to a Pathogenic Variant: An Educational Case Report
title_sort atypical adpkd due to a pathogenic variant an educational case report
url https://doi.org/10.1177/20543581231203054
work_keys_str_mv AT jessicakachmar atypicaladpkdduetoapathogenicvariantaneducationalcasereport
AT zakielhaffaf atypicaladpkdduetoapathogenicvariantaneducationalcasereport
AT guillaumebollee atypicaladpkdduetoapathogenicvariantaneducationalcasereport